If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Digital Technology » Digital Technology and Innovation
Download FREE Excerpt
23 Info Graphics
15 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The rapid pace of technological innovation in the healthcare industry has enabled many biopharma and medical device organizations to build “connected healthcare applications” that enhance an existing device or drug delivery system and capture critical patient treatment data.
Biopharma and other healthcare industries see the value in connected healthcare applications that improve quality of care, patient engagement, adherence, outcomes and, at the same time, produce high business impact across therapeutic areas.
Best Practices, LLC undertook this benchmarking research to help biopharma and medical device leaders better understand the current drivers and impacts of connected healthcare applications. This study also looks at investment and performance measurement insofar as these connected apps.
I. Understanding the Connected Healthcare Applications of Competitors
Best Practices, LLC engaged 29 leaders from 26 life sciences organizations through a benchmarking survey in this research. Deep-dive interviews were conducted with five biopharma executives to provide further insight.
Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; Consulting; Manufacturing; Biotech; Consumer Products; Medical Device; Clinical Research; Science; Technology
Abbott; AbbVie; Alnylam Pharmaceuticals; Ashfield Healthcare; Astellas; AstraZeneca; Bayer; BioMarin; Bristol-Myers Squibb; Cadila Pharmaceuticals; Evolution Road; GE Healthcare; Johnson & Johnson; Kaleidoscope Health and Care; LifePlus; Mallinckrodt; Merck; Merck KGaA; Novartis; Pharm-Olam; Phillips-Medisize; Science 37; Seca - Precision For Health; Takeda Pharmaceuticals; Thermo Fisher Scientific; Wipro
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.